Last reviewed · How we verify

NCT06957847: WIHYP-GP

Clinical Validation of the Blood Pressure Measuring Device Withings BPM Pro 2 (WIHYP-GP)

Completed NA Last updated 18 February 2026
What this trial tests

NA trial testing Blood pressure measurement in Hypertension in 89 participants. Completed in 18 November 2025.

Timeline
28 April 2025
Primary endpoint
21 August 2025
18 November 2025

Quick facts

Lead sponsorWithings
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposedevice feasibility
Enrollment89
Start date28 April 2025
Primary completion21 August 2025
Estimated completion18 November 2025
Sites1 location across Armenia

Drugs / interventions tested

Conditions studied

Sponsor

Withings — full company profile →

Who can join

18 and older, any sex, with Hypertension. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of the study is to assess the accuracy of the automatic oscillometric BP measuring device at the brachial level, the WITHINGS BPM Pro 2, in the general population

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Blood pressure measurement

Trials testing the same drug.

Other recruiting trials for Hypertension

Currently open trials in the same condition.

Other Withings trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06957847.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing